Related Experiment Video
Updated: Aug 24, 2026
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Tuberous sclerosis complex: from Drosophila to human disease
Duojia Pan1, Jixin Dong, Yong Zhang
1Department of Physiology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390-9040, USA. Duojia.Pan@UTSouthwestern.edu
Abstract:
Tuberous sclerosis complex (TSC) is a human syndrome characterized by a widespread development of benign tumors. This disease is caused by mutations in the TSC1 or TSC2 tumor suppressor genes; the molecular mechanisms underlying the activity of these have long been elusive. Recent studies of Drosophila and mammalian cells demonstrate that the TSC1-TSC2 complex functions as GTPase activating protein against Rheb - a Ras-like small GTPase, which in turn regulates TOR signaling in nutrient-stimulated cell growth. These findings provide a new paradigm for how proteins involved in nutrient sensing could function as tumor suppressors and suggest novel therapeutic targets against TSC. Here, we review these exciting developments with an emphasis on Drosophila studies and discuss how Drosophila can be a powerful model system for an understanding of the molecular mechanisms of the activity of human disease genes.
Insights
Tuberous sclerosis complex (TSC) is caused by mutations in TSC1/TSC2 genes. These genes form a complex that acts as a GTPase activating protein, regulating cell growth and offering new therapeutic targets for TSC.
Area of Science:
- Molecular Biology
- Genetics
- Cellular Biology
Background:
- Tuberous sclerosis complex (TSC) is a genetic disorder causing benign tumor development.
- Mutations in TSC1 or TSC2 tumor suppressor genes underlie TSC.
- The precise molecular functions of TSC1 and TSC2 have remained largely unknown.
Purpose of the Study:
- To review recent findings on the molecular mechanisms of TSC1 and TSC2.
- To highlight the role of the TSC1-TSC2 complex in regulating cell growth.
- To emphasize the utility of Drosophila as a model system for studying TSC.
Main Methods:
- Review of recent studies in Drosophila and mammalian cells.
- Analysis of the TSC1-TSC2 complex's function as a GTPase activating protein (GAP).
- Investigation of Rheb GTPase regulation and its impact on TOR signaling.
Main Results:
- The TSC1-TSC2 complex functions as a GTPase activating protein (GAP) for Rheb.
- Rheb regulates nutrient-stimulated cell growth via TOR signaling.
- This reveals a paradigm for nutrient-sensing tumor suppressors.
Conclusions:
- The TSC1-TSC2 complex's GAP activity against Rheb is a key mechanism in TSC.
- Understanding this pathway offers novel therapeutic strategies for TSC.
- Drosophila serves as a valuable model for elucidating human disease gene functions.
